Certolizumab pegol Active Not Recruiting Phase 3 Trials for Ankylosing Spondylitis (AS) / Axial Spondyloarthrithis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02505542Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo